Aqneursa: A Glimmer of Hope for Niemann-Pick Type C Disease? The Future of Rare Disease Treatments The recent European Medicines Agency (EMA) recommendation for Aqneursa, a potential new treatment for the neurological manifestations of Niemann-Pick type C (NPC) disease, marks a significant moment in the fight against this devastating rare disorder. As a journalist specializing … Read more
DMD Gene Therapy: Where Do We Go From Here? The recent decision by the European Medicines Agency (EMA) to not grant marketing authorization for delandistrogene moxeparvovec (Elevidys) for Duchenne muscular dystrophy (DMD) treatment highlights the complexities and challenges within gene therapy development. This news, coupled with serious safety concerns, prompts a crucial question: What’s next … Read more
Aqneursa: A Glimmer of Hope for Niemann-Pick Type C Disease? Examining the Future of Rare Disease Treatments The recent recommendation by the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) to grant marketing authorization for Aqneursa (levacetylleucine) in the European Union marks a significant moment for individuals affected by Niemann-Pick type C … Read more
AI’s Rise in Mammography: A Glimpse into the Future of Breast Cancer Screening The realm of medical technology is undergoing a seismic shift, with Artificial Intelligence (AI) emerging as a powerful ally in the fight against diseases. A recent study, as highlighted in European Radiology, showcased an AI tool’s impressive performance in mammography, potentially revolutionizing … Read more
The Future of General Practice: Navigating a Changing Landscape The landscape of general practice in England is undergoing a significant transformation. A recent report from the Royal College of General Practitioners (RCGP) highlights a concerning trend: a shrinking pool of GP partners. This shift has major implications for the delivery of primary care services and … Read more
Early Heart Health: A Revolution in Cardiovascular Risk Assessment The landscape of cardiovascular health is undergoing a significant shift. Experts are increasingly advocating for a proactive approach, emphasizing lifetime risk assessments over the traditional 10-year projections. This evolving perspective, highlighted at the British Cardiovascular Society Annual Conference 2025, has profound implications for how we approach … Read more
UK Heart Failure Crisis: Thousands Missing Out on Life-Saving Treatments The UK faces a silent crisis. Thousands of individuals with advanced heart failure are not receiving referrals for potentially life-saving treatments like heart transplants and left ventricular assist devices (LVADs). This critical issue, highlighted at the British Cardiovascular Society Annual Conference, demands immediate attention. The … Read more
Antibiotic-Resistant Gonorrhoea: A Looming Threat and What It Means for You The UK Health Security Agency (UKHSA) recently released data that paints a complex picture of sexually transmitted infections (STIs) in England. While there’s good news in some areas, a growing concern looms: the rise of antibiotic-resistant gonorrhoea. As a health journalist, I’ve been following … Read more
The Creon Crisis: Navigating the Ongoing Shortage and Future Trends in PERT Supply The UK pharmacy landscape is currently grappling with a significant challenge: a severe shortage of pancreatic enzyme replacement therapy (PERT), particularly Creon. This issue, affecting patients with conditions like cystic fibrosis and pancreatic cancer, necessitates a deep dive into the current situation … Read more
Azithromycin Under the Microscope: A Look at Changing Antibiotic Guidelines and Future Trends The European Medicines Agency (EMA) is taking a closer look at how we use the antibiotic azithromycin. Recent recommendations from the Committee for Medicinal Products for Human Use (CHMP) suggest significant changes, aiming to optimize its use and combat the growing threat … Read more